|
1
|
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.
|
Lancet Oncol
|
2009
|
3.07
|
|
2
|
Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study.
|
J Clin Oncol
|
2011
|
1.79
|
|
3
|
Children's Oncology Group's 2013 blueprint for research: renal tumors.
|
Pediatr Blood Cancer
|
2012
|
1.32
|
|
4
|
Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.
|
J Nucl Med
|
2013
|
1.25
|
|
5
|
Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group.
|
Clin Cancer Res
|
2011
|
1.16
|
|
6
|
A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study.
|
Ann Surg
|
2012
|
1.04
|
|
7
|
miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples.
|
Clin Cancer Res
|
2011
|
1.03
|
|
8
|
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.
|
Pediatr Blood Cancer
|
2009
|
1.00
|
|
9
|
A genome-wide association study identifies susceptibility loci for Wilms tumor.
|
Nat Genet
|
2012
|
0.97
|
|
10
|
Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology Group.
|
Cancer
|
2013
|
0.96
|
|
11
|
Clear cell sarcoma of the kidney demonstrates an embryonic signature indicative of a primitive nephrogenic origin.
|
Genes Chromosomes Cancer
|
2014
|
0.93
|
|
12
|
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee.
|
Pediatr Blood Cancer
|
2012
|
0.91
|
|
13
|
CASZ1b, the short isoform of CASZ1 gene, coexpresses with CASZ1a during neurogenesis and suppresses neuroblastoma cell growth.
|
PLoS One
|
2011
|
0.91
|
|
14
|
Detection of preoperative wilms tumor rupture with CT: a report from the Children's Oncology Group.
|
Radiology
|
2012
|
0.90
|
|
15
|
Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group.
|
Int J Mol Imaging
|
2012
|
0.90
|
|
16
|
Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee.
|
J Pediatr Surg
|
2013
|
0.89
|
|
17
|
Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma.
|
Cancer Res
|
2012
|
0.88
|
|
18
|
Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: a Pediatric Oncology Group study: a report from the Children's Oncology Group.
|
Pediatr Blood Cancer
|
2012
|
0.88
|
|
19
|
Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group.
|
Pediatr Dev Pathol
|
2014
|
0.86
|
|
20
|
Mentoring in pediatric oncology: a report from the Children's Oncology Group Young Investigator Committee.
|
J Pediatr Hematol Oncol
|
2013
|
0.78
|
|
21
|
Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children's Oncology Group.
|
Pediatr Radiol
|
2014
|
0.75
|